Vitamin D supplementation shows no significant effect on acute respiratory infections overall, but children and daily low ...
It's called the Camp Virus, and it's never been in North America, ever, until now. It's part of the lethal Henipaviruses and ...
Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...
There's an arms race in medicine—scientists design drugs to treat lethal bacterial infections, but bacteria can evolve ...
Understanding resilience—the ability of injured lung tissue to heal and regenerate—may be key to advancing the treatment and ...
Kilitch Drugs(I) Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 525.65 Crore) operating in Pharmaceuticals sector. Kilitch Drugs(I) Ltd. key Products/Revenue ...
Stock gave a 3 year return of 21.75% as compared to Nifty Smallcap 100 which gave a return of 46.82%. (as of last trading session) Stock Returns vs Nifty Pharma Stock generated 21.75% return as ...